1. Market Research
  2. > Pharmaceutical Market Trends
  3. > End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) 35
Nov 01, 2016: Ionis Pharmaceuticals Reports Positive Phase 2 Data for IONIS-FXI Rx in Patients with End-Stage Renal Disease on Hemodialysis 35
Clinical Trial Profile Snapshots 36
Appendix 384
Abbreviations 384
Definitions 384
Research Methodology 385
Secondary Research 385
About GlobalData 386
Contact Us 386
Disclaimer 386
Source 387

List of Tables
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region, 2016* 6
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2016* 16
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 19
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2016* 21
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 22
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 23
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase, 2016* 24
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 25
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 26
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 27
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 28
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 29
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 31
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 33
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 34

List of Figures
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2016* 15
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2016* 20
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 22
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 23
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 24
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 25
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 26
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 27
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 28
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 29
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 30
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 32
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 34
GlobalData Methodology 385

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016

Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by Global Data

Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016" provides an overview ...

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • September 2016
  • by Global Data

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials ...

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2016

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Polycystic Kidney Disease Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Polycystic Kidney Disease Global Clinical Trials Review, H2, 2016" provides an overview ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.